Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects

Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects

Abstract Sarcoma is a malignant tumor that originates from mesenchymal tissue. The common treatment for sarcoma is surgery supplemented with radiotherapy and chemotherapy. However, patients have a 5-year survival rate of only approximately 60%, and sarcoma cells are highly resistant to chemotherapy....

Full description

Bibliographic Details
Main Authors: Jing Zeng, Xianghong Zhang, Zhengjun Lin, Yu Zhang, Jing Yang, Pengcheng Dou, Tang Liu
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Experimental Hematology & Oncology
Subjects:
Ferroptosis
Sarcoma
Mechanism
Prognosis prediction
Drug resistance
Online Access:https://doi.org/10.1186/s40164-024-00498-3

Internet

https://doi.org/10.1186/s40164-024-00498-3

Similar Items